Cargando…
Employing QbD strategies to assess the impact of cell viability and density on the primary recovery of monoclonal antibodies
Quality by Design (QbD) is one of the most important tools for the implementation of Process Analytical Technology (PAT) in biopharmaceutical production. For optimal characterization of a monoclonal antibody (mAb) upstream process a stepwise approach was implemented. The upstream was divided into th...
Autores principales: | Wohlenberg, Ole Jacob, Kortmann, Carlotta, Meyer, Katharina V., Scheper, Thomas, Solle, Dörte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893750/ https://www.ncbi.nlm.nih.gov/pubmed/36751474 http://dx.doi.org/10.1002/elsc.202200056 |
Ejemplares similares
-
Implementation of QbD strategies in the inoculum expansion of a mAb production process
por: Böhl, Ole Jacob, et al.
Publicado: (2020) -
Optimization of a mAb production process with regard to robustness and product quality using quality by design principles
por: Wohlenberg, Ole Jacob, et al.
Publicado: (2022) -
Stress‐induced increase of monoclonal antibody production in CHO cells
por: Schellenberg, Jana, et al.
Publicado: (2022) -
Early Implementation of QbD in Biopharmaceutical Development: A Practical Example
por: Zurdo, Jesús, et al.
Publicado: (2015) -
Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach
por: Dobó, Dorina Gabriella, et al.
Publicado: (2022)